In-Body cancer killers: new CAR-T therapy targets Hard-to-Treat blood cancers
Disease control
Not yet recruiting
This early-stage study tests the safety of a new type of immunotherapy for people with relapsed or refractory plasma cell neoplasms, a type of blood cancer. Instead of modifying cells in a lab, the treatment creates cancer-fighting CAR-T cells directly inside the body, targeting …
Phase: EARLY_PHASE1 • Sponsor: Liping Dou • Aim: Disease control
Last updated May 26, 2026 08:35 UTC